European Federation for Medicinal Chemistry - EFMC

UNITED KINGDOM64The Biological and Medicinal Chemistry Sector (BMCS)of the Royal Society of Chemistry (RSC)National Adhering OrganisationsMissionFoundedMembersMember profilePostal addressTelephone - FaxE-mail - WebsiteActivitiesThe BMCS aims to further the interests of all members of the RSC, bothindustrial and academic, involved in the pursuit and understanding ofbiologically active molecules. It also acts to promote public awarenessof the crucial role played by chemistry in the modern industrialenvironment.1995 (Formerly Fine Chemicals & Medicinals Group)1020 members, 600 of whom are medicinal chemistsAcademia + IndustryStuart Cameron - Peakdale Molecular Ltd. - Peakdale Science ParkSheffield Road, Chapel-en-le-FrithSK23 0PG High Peak United Kingdom+44 (1298) 816 700 Ext. 6841 / +44 (1298) 816 701http://www.rsc.org/bmcsThe Biological and Medicinal Chemistry Sector (BMCS) is a Sector of the Industry & Technology Forum of the Royal Society ofChemistry (RSC) in the UK. The annually elected committee is primarily responsible for the organisation of scientific meetingsand symposia, supporting educational activities in the UK, and advising the Society on policies that directly affect the BMCS.Specifically, the BMCS aims to further the interests of all members of the RSC, both industrial and academic, involved in thepursuit and understanding of biologically active molecules. The predominant areas thus include pharmaceuticals, agrochemicals,flavours and fragrances. It also acts to promote public awareness of the crucial role played by chemistry in the modernindustrial environment. The BMCS is particularly active in the organisation of scientific meetings and does so in collaborationwith a wide variety of other groups both within and external to the RSC. Over the past few years the BMCS has been especiallyactive in promoting some of the important interfacial areas in which chemists are intimately involved. In recent years, it hasheld internationally attended meetings with the EFMC, the Society for Chemical Industry, the Society for Medicines Researchand with the Biochemical Society. On average six or more scientific meetings are held each year. Support for educationalactivities, such as the running of lectures and day schools, and the provision of equipment are also an important componentof BMCS activities. Indeed, some of these initiatives are now established as annual events. The BMCS also administers annualawards that acknowledge major scientific achievements in both academia and industry that have been carried out within theUK. The BMCS provides a significant input into Royal Society of Chemistry strategic initiatives.• Seminar organised by RSC Law Group- Review of Recent IP Case Law Seminar(November 29, 2012), London, UK• 6 th Annual Biological & Medicinal Chemistry PostgraduateSymposium(December 14, 2012), Cambridge, United Kindgdom• Protein-Protein Interactions: Emerging Scienceand Therapeutic Potential(January 16-17, 2013), London, UK• Fragments 2013: 4th RSC-BMCS fragment-basedDrug Discovery meeting(4-5 March, 2013), STFC Rutherford Appelton Laboratory,Oxfordshire, UK• 4 th RSC/SCI Symposium on Ion Channels as Therapeutic Targets(18-19 March, 2013), Abington Hall, Cambridge, UK• Proteinase 2013: 8th RSC.SCI Symposiumon Proteinase Inhibitor Design(15-16 April, 2013), Novartis, Basel, Switzerland• 24 th Symposium on Medicinal Chemistry in Eastern England(25th April, 2012), The Fielder Centre, University of Hertfordshire,Hatfield, UK• 17 th RSC/SCI Medicinal Chemistry Symposium(8-11 September, 2013), Churchill College, Cambridge, UK• 2 nd RSC/SCI Symposium on Continuous Processingand Flow Chemistry(24-25 September, 2013), Novartis, Horsham, UK• 6 th BMCS Postgraduate Biologicaland Medicinal Chemistry Symposium(12th December 2013), Chemistry Department, University ofCambridge, Cambridge, UKPresidentSecretaryEFMC-DelegateDr Phil JONES (Allsci)Dr Stuart CAMERON (Peakdale)Dr David ALKER (David Alker Associates)